Los Angeles-Based Pelage Launches Phase 2a Trial: A New Era...
Pelage Pharmaceuticals, based in Los Angeles, has announced the commencement of its Phase 2a clinical trial for a groundbreaking treatment targeting androgenetic alopecia, commonly known as pattern hair loss. This...
